Conning Inc’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$34.6M Sell
141,649
-13,144
-8% -$3.06M 1.15% 39
2025
Q4
$32M Sell
154,793
-23,887
-13% -$4.72M 1.07% 50
2025
Q3
$33.1M Sell
178,680
-30,403
-15% -$5.21M 1.1% 41
2025
Q2
$31.9M Buy
209,083
+7,627
+4% +$1.17M 1.1% 53
2025
Q1
$33.4M Sell
201,456
-27,811
-12% -$4.35M 1.17% 47
2024
Q4
$33.2M Buy
229,267
+15,180
+7% +$2.35M 1.16% 50
2024
Q3
$34.7M Sell
214,087
-13,645
-6% -$2.17M 1.15% 53
2024
Q2
$33.2M Buy
227,732
+5,562
+3% +$827K 1.2% 50
2024
Q1
$35.1M Buy
222,170
+19,449
+10% +$3.1M 1.15% 52
2023
Q4
$31.7M Sell
202,721
-10,335
-5% -$1.58M 1.1% 50
2023
Q3
$33.1M Sell
213,056
-6,387
-3% -$1.05M 1.21% 38
2023
Q2
$36.3M Sell
219,443
-11,819
-5% -$1.91M 1.21% 27
2023
Q1
$35.8M Buy
231,262
+26,067
+13% +$4.21M 1.2% 35
2022
Q4
$36.2M Sell
205,195
-2,902
-1% -$501K 1.18% 28
2022
Q3
$34M Sell
208,097
-27,094
-12% -$4.58M 1.21% 18
2022
Q2
$41.7M Sell
235,191
-17,129
-7% -$3.05M 1.25% 26
2022
Q1
$44.7M Sell
252,320
-33,979
-12% -$5.78M 1.22% 31
2021
Q4
$48.9M Buy
286,299
+11,865
+4% +$1.94M 1.3% 35
2021
Q3
$44.3M Sell
274,434
-16,108
-6% -$2.75M 1.27% 36
2021
Q2
$47.8M Sell
290,542
-2,817
-1% -$466K 1.39% 31
2021
Q1
$48.2M Sell
293,359
-6,784
-2% -$1.1M 1.45% 30
2020
Q4
$47.2M Buy
300,143
+31,679
+12% +$4.67M 1.5% 26
2020
Q3
$40M Buy
268,464
+9,400
+4% +$1.39M 1.41% 32
2020
Q2
$36.4M Sell
259,064
-14,510
-5% -$2.11M 1.35% 34
2020
Q1
$35.9M Sell
273,574
-14,090
-5% -$2M 1.53% 24
2019
Q4
$42M Buy
287,664
+7,591
+3% +$1.03M 1.38% 33
2019
Q3
$36.2M Buy
280,073
+4,845
+2% +$638K 1.25% 38
2019
Q2
$38.3M Sell
275,228
-31,572
-10% -$4.37M 1.27% 39
2019
Q1
$42.9M Buy
306,800
+13,439
+5% +$1.8M 1.34% 30
2018
Q4
$37.9M Sell
293,361
-41,332
-12% -$5.77M 1.29% 33
2018
Q3
$46.2M Sell
334,693
-22,488
-6% -$2.99M 1.37% 22
2018
Q2
$43.3M Sell
357,181
-19,644
-5% -$2.45M 1.32% 21
2018
Q1
$48.3M Buy
376,825
+42,978
+13% +$5.81M 1.55% 4
2017
Q4
$46.6M Sell
333,847
-24,817
-7% -$3.46M 1.54% 2
2017
Q3
$46.6M Buy
358,664
+7,245
+2% +$960K 1.59% 4
2017
Q2
$46.5M Sell
351,419
-9,599
-3% -$1.22M 1.69% 2
2017
Q1
$45M Buy
361,018
+18,970
+6% +$2.27M 1.66% 3
2016
Q4
$39.4M Buy
342,048
+12,239
+4% +$1.41M 1.57% 5
2016
Q3
$39M Sell
329,809
-19,607
-6% -$2.38M 1.55% 5
2016
Q2
$42.4M Sell
349,416
-9,101
-3% -$1.03M 1.75% 3
2016
Q1
$38.8M Sell
358,517
-35,254
-9% -$3.65M 1.63% 5
2015
Q4
$40.4M Sell
393,771
-14,412
-4% -$1.45M 1.73% 3
2015
Q3
$38.1M Sell
408,183
-1,991
-0.5% -$193K 1.67% 4
2015
Q2
$40M Buy
410,174
+17,333
+4% +$1.74M 1.64% 3
2015
Q1
$39.5M Buy
392,841
+108,471
+38% +$11M 1.68% 3
2014
Q4
$29.7M Buy
284,370
+2,384
+0.8% +$251K 1.45% 9
2014
Q3
$30.1M Buy
281,986
+7,046
+3% +$731K 1.57% 5
2014
Q2
$28.8M Buy
274,940
+4,399
+2% +$445K 1.53% 7
2014
Q1
$26.6M Buy
270,541
+13,897
+5% +$1.29M 1.56% 5
2013
Q4
$23.5M Buy
256,644
+47,733
+23% +$4.4M 1.46% 8
2013
Q3
$18.1M Buy
208,911
+228
+0.1% +$20.5K 1.4% 11
2013
Q2
$17.9M Buy
+208,683
New +$17.7M 1.48% 7

Other funds holding JNJ

Conning Inc's JNJ Position: Q1 2026 in Review

Conning Inc reduced its Johnson & Johnson (JNJ) stake by 8.5% in Q1 2026, selling an estimated $3.06M and leaving 141,649 shares worth $34.6M. The position accounts for 1.15% of the portfolio, ranked #39.

Conning Inc first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $48.9M in Q4 2021. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Conning Inc held 141,649 shares of Johnson & Johnson worth $34.6M as of Q1 2026.
  • Conning Inc sold 13,144 Johnson & Johnson shares in Q1 2026, an estimated $3.06M.
  • Johnson & Johnson made up 1.15% of Conning Inc's portfolio in Q1 2026, its #39 holding.
  • Conning Inc first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Conning Inc's Johnson & Johnson position peaked at $48.9M in Q4 2021.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Conning Inc's 13F filing for Q1 2026, filed 30 Apr 2026.